– CANADA, Vancouver – Wellbeing Digital Sciences Inc. (NEO: MEDI) | OTC: KONEF | FRA: SQ2), a mental healthcare company today announced the appointment of Mohammad Sharifi to its Board of Directors, effective November 22, 2022.
“We are pleased to welcome Mohammad to the Board. Mohammad’s leadership experience will be invaluable to the Company as we grow our business and pursue our mission to enrich lives through enhanced mental health services,” said CEO, Najla Guthrie.
Mohammad Sharifi will also join the Audit Committee and Governance Committee.
About Mohammad Sharifi
Mohammad Sharifi has extensive experience in marketing and digital communications which has spanned the consumer products industry. Mr. Sharifi has also held various senior marketing roles at several companies, including Telus Telecommunication where he was responsible for the growth and marketing of their business. Mohammad joins at a key point in the Company’s growth. His knowledge and experience will be vital as we continue our plans to fundamentally change the mental health industry by providing the research, education, and distribution needed to make innovative treatments accessible.
About Wellbeing Digital Sciences Inc.
Wellbeing Digital Sciences Inc. is an evidence-based mental healthcare company focused on developing and implementing innovative clinical treatment solutions, including psychedelic medicine and digital therapeutics, as supported by clinical research. Its mission is supported by a network of North American clinics that provide forward-thinking therapies and other types of treatment to patients as well as through a contract research organization that offers clinical trial services to clients pursuing drug development.
For more information: https://www.wellbeingdigital.co/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
